FLOLAN (GlaxoSmithKline LLC)


Welcome to the PulseAid listing for the FLOLAN drug offered from GlaxoSmithKline LLC. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: GlaxoSmithKline LLC
NON-PROPRIETARY NAME: epoprostenol sodium
SUBSTANCE NAME: EPOPROSTENOL SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1995-12-08
END MARKETING DATE: 0000-00-00


FLOLAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFLOLAN from GlaxoSmithKline LLC
LABELER NAME: GlaxoSmithKline LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 1995-12-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0173-0517_b9f0d662-3e2d-4681-944d-cd320ff65321
PRODUCT NDC: 0173-0517
APPLICATION NUMBER: NDA020444

Other EPOPROSTENOL SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actelion Pharmaceuticals US, Inc.Veletri
GlaxoSmithKline LLCFLOLAN
Teva Parenteral Medicines, Inc.Epoprostenol Sodium